Last reviewed · How we verify

NCT04953507

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Pulse Oximeter

Completed NA Last updated 18 July 2025
What this trial tests

NA trial testing Thermal Radiofrequency in Analgesia in 54 participants. Completed in 25 February 2025.

Timeline
3 July 2021
Primary endpoint
10 February 2025
25 February 2025

Quick facts

Lead sponsorNational Cancer Institute, Egypt
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment54
Start date3 July 2021
Primary completion10 February 2025
Estimated completion25 February 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

National Cancer Institute, Egypt

Who can join

Adults 18 to 70, female only, with Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare the efficacy of T2, T3 sympathetic block using thermal radiofrequency versus chemical neurolysis in postmastectomy pain syndrome using perfusion index derived from pulse oximetry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Analgesia

Currently open trials in the same condition.

Other National Cancer Institute, Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04953507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing